Yooyoung Pharmaceutical Co., Ltd.

Quick facts

Phase 3 pipeline

• Active comparator: Synovian Inj. · Orthopedics / Rheumatology
  Synovian is a hyaluronic acid-based intra-articular injection that lubricates and cushions the joint to reduce pain and improve mobility in osteoarthritis.
• Simdax · Cardiovascular
• YYC301-1 & YYC301-2 & YYC301-3
  YYC301-1, YYC301-2, and YYC301-3 are investigational drugs with unknown mechanisms of action.
• YYC405-T · Diabetes
  YYC405-T is a small molecule that targets the SGLT2 receptor.
• YYC506 · Diabetes
  YYC506 is a small molecule that targets the SGLT2 receptor.

Phase 1 pipeline

• YYC506-A
• YYC506-T
• YYD601 1
• YYD601 2
• YYD601 3

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Yooyoung Pharmaceutical Co., Ltd. portfolio CI brief
• Yooyoung Pharmaceutical Co., Ltd. pipeline updates RSS